Risk of Colorectal Cancer after Solid Organ Transplantation in the United States

American Journal of Transplantation

Volumn 16, Issue 3, 2016, Pages 960-967

  Safaeian, M ^a   Robbins, H A ^a,c   Berndt, S I ^a   Lynch, C F ^b   Fraumeni, J F ^a   Engels, E A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLATE MOFETIL; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CHILD; COLORECTAL CANCER; CYSTIC FIBROSIS; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; INFANT; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORGAN TRANSPLANTATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; UNITED STATES; ADVERSE EFFECTS; COLORECTAL NEOPLASMS; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; REGISTER; RISK ASSESSMENT;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TRANSPLANT RECIPIENTS; UNITED STATES;

EID: 84959525341     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13549     Document Type: Article

References (35)

1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59-67.
2. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al., Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901.
3. Adami J, Gabel H, Lindelof B, et al., Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227.
4. Vajdic CM, van Leeuwen MT., Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-1754.
5. Villeneuve PJ, Schaubel DE, Fenton SS, et al., Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7: 941-948.
6. Kyllonen L, Salmela K, Pukkala E., Cancer incidence in a kidney-transplanted population. Transpl Int 2000; 13 (Suppl 1): S394-S398.
7. Collett D, Mumford L, Banner NR, Neuberger J, Watson C., Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit. Am J Transplant 2010; 10: 1889-1896.
8. Jiang Y, Villeneuve PJ, Wielgosz A, et al., The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant 2010; 10: 637-645.
9. Jiang Y, Villeneuve PJ, Fenton SS, et al., Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort study. Liver Transpl 2008; 14: 1588-1597.
10. Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H., Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transpl 2008; 14: 1428-1436.
11. Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB., Cancer risk in cystic fibrosis: A 20-year nationwide study from the United States. J Natl Cancer Inst 2013; 105: 122-129.
12. Meyer KC, Francois ML, Thomas HK, et al., Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 2011; 10: 366-369.
13. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR., High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009; 50: 158-164.
14. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO., Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointest Endosc 2002; 56: 48-54.
15. Tsaitas C, Semertzidou A, Sinakos E., Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol 2014; 6: 178-187.
16. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-637.
17. Vajdic CM, McDonald SP, McCredie MR, et al., Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831.
18. Roithmaier S, Haydon AM, Loi S, et al., Incidence of malignancies in heart and/or lung transplant recipients: A single-institution experience. J Heart Lung Transplant 2007; 26: 845-849.
19. Kwon JH, Koh SJ, Kim JY, et al., Prevalence of advanced colorectal neoplasm after kidney transplantation: Surveillance based on the results of screening colonoscopy. Dig Dis Sci 2015; 60: 1761-1769.
20. Stewart T, Henderson R, Grayson H, Opelz G., Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res 1997; 3: 51-55.
21. Giovannucci E, Wu K., Cancers of the colon and rectum. In:, Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York, NY: Oxford University Press, 2006; p. 809-829.
22. Verdonk RC, Dijkstra G, Haagsma EB, et al., Inflammatory bowel disease after liver transplantation: Risk factors for recurrence and de novo disease. Am J Transplant 2006; 6: 1422-1429.
23. Hampton DD, Poleski MH, Onken JE., Inflammatory bowel disease following solid organ transplantation. Clin Immunol 2008; 128: 287-293.
24. Jorgensen KK, Lindstrom L, Cvancarova M, et al., Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: A Nordic multicenter study. Scand J Gastroenterol 2012; 47: 1021-1029.
25. Jorgensen KK, Lindstrom L, Cvancarova M, et al., Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11: 517-523.
26. Vera A, Gunson BK, Ussatoff V, et al., Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983-1988.
27. Chapman R, Fevery J, Kalloo A, et al., Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-678.
28. IARC Monographs on the evaluation of carcinogenic risks to humans, volume 100-A. A review of human carcinogens. 2008.
29. Robbins HA, Clarke CA, Arron ST, et al., Melanoma risk and survival among organ transplant recipients. J Invest Dermatol 2015; 135: 2657-2665.
30. Clarke CA, Robbins HA, Tatalovich Z, et al., Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst 2015; 107.
31. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA., Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol 2014; 12: 1541-1549.e3.
32. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA., HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013; 13: 3202-3209.
33. Shapiro JA, Klabunde CN, Thompson TD, et al., Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012; 21: 895-904.
34. Schoen RE, Pinsky PF, Weissfeld JL, et al., Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345-2357.
35. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl 3): S1-155.